Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosis

被引:62
作者
Choi, Eun Jeong [1 ]
Jung, Jae Yeon [1 ]
Kim, Gun-Hee [1 ]
机构
[1] Duksung Womens Univ, Plant Resources Res Inst, Seoul 132714, South Korea
基金
新加坡国家研究基金会;
关键词
genistein; 3T3-L1; cells; MCF-7; proliferation; differentiation; estrogen receptor-alpha; HUMAN BREAST-CANCER; CYCLIN D1; EPIDEMIOLOGIC EVIDENCE; KINASE-ACTIVITY; PHYTOESTROGENS; DAIDZEIN; PREVENTION; GROWTH; RISK; AMPLIFICATION;
D O I
10.3892/etm.2014.1771
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study investigated the effect of the phytochemical genistein on the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of estrogen receptor-alpha (ER alpha) expression and the induction of apoptosis. When MCF-7 human breast cancer cells were treated with 50, 100, 150 and 200 mu M genistein for 24,48 or 72 h, cell growth was significantly decreased in a concentration-dependent manner. Notably, the patterns of ERa expression and proliferation in MCF-7 cells treated with genistein were similar. Furthermore, ER alpha expression in differentiating 3T3-L1 cells was significantly inhibited by 48 h treatment with 50 mu M genistein, which was selected based on the results of cytotoxicity assays on 3T3-L1 preadipocytes [lactate dehydrogenase (LDH) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assays]. Under the same conditions, genistein-induced apoptotic features were observed in MCF-7 and differentiating 3T3-L1 cells. This observation is supported by the finding that B-cell lymphoma 2 (Bcl-2) expression was reduced while that of Bcl-2-associated X protein (Bax) was induced by genistein. The results of the present study suggest that an ER alpha-related pathway and the induction of apoptosis are involved in the proliferation of MCF-7 cells and the differentiation of 3T3-L1 cells.
引用
收藏
页码:454 / 458
页数:5
相关论文
共 36 条
[1]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[2]  
Barbareschi M, 1997, INT J CANCER, V74, P171, DOI 10.1002/(SICI)1097-0215(19970422)74:2<171::AID-IJC5>3.0.CO
[3]  
2-W
[4]   CYCLIN D1 PROTEIN EXPRESSION AND FUNCTION IN HUMAN BREAST-CANCER [J].
BARTKOVA, J ;
LUKAS, J ;
MULLER, H ;
LUTZHOFT, D ;
STRAUSS, M ;
BARTEK, J .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :353-361
[5]   Mechanisms of estrogen receptor signaling:: Convergence of genomic and nongenomic actions on target genes [J].
Björnström, L ;
Sjöberg, M .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (04) :833-842
[6]   Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities [J].
Bovee, Toine F. H. ;
Schoonen, Willem G. E. J. ;
Hamers, Astrid R. M. ;
Bento, Marta Jorge ;
Peijnenburg, Ad A. C. M. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 390 (04) :1111-1119
[7]  
BUCKLEY MF, 1993, ONCOGENE, V8, P2127
[8]   Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E [J].
Butt, AJ ;
McNeil, CM ;
Musgrove, EA ;
Sutherland, RL .
ENDOCRINE-RELATED CANCER, 2005, 12 :S47-S59
[9]   Antiproliferative activity of daidzein and genistein may be related to ERα/c-erbB-2 expression in human breast cancer cells [J].
Choi, Eun Jeong ;
Kim, Gun-Hee .
MOLECULAR MEDICINE REPORTS, 2013, 7 (03) :781-784
[10]  
Choi EJ, 2008, MOL MED REP, V1, P239